1. Home
  2. SCPH vs MTA Comparison

SCPH vs MTA Comparison

Compare SCPH & MTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCPH
  • MTA
  • Stock Information
  • Founded
  • SCPH 2013
  • MTA 1983
  • Country
  • SCPH United States
  • MTA Canada
  • Employees
  • SCPH N/A
  • MTA N/A
  • Industry
  • SCPH Biotechnology: Pharmaceutical Preparations
  • MTA
  • Sector
  • SCPH Health Care
  • MTA
  • Exchange
  • SCPH Nasdaq
  • MTA Nasdaq
  • Market Cap
  • SCPH 299.0M
  • MTA 506.2M
  • IPO Year
  • SCPH 2017
  • MTA N/A
  • Fundamental
  • Price
  • SCPH $5.63
  • MTA $5.53
  • Analyst Decision
  • SCPH Buy
  • MTA Hold
  • Analyst Count
  • SCPH 3
  • MTA 1
  • Target Price
  • SCPH $12.00
  • MTA $4.50
  • AVG Volume (30 Days)
  • SCPH 2.4M
  • MTA 913.3K
  • Earning Date
  • SCPH 11-12-2025
  • MTA 11-13-2025
  • Dividend Yield
  • SCPH N/A
  • MTA N/A
  • EPS Growth
  • SCPH N/A
  • MTA N/A
  • EPS
  • SCPH N/A
  • MTA N/A
  • Revenue
  • SCPH $49,969,000.00
  • MTA $8,167,999.00
  • Revenue This Year
  • SCPH $104.30
  • MTA $123.39
  • Revenue Next Year
  • SCPH $76.06
  • MTA $64.87
  • P/E Ratio
  • SCPH N/A
  • MTA N/A
  • Revenue Growth
  • SCPH 107.79
  • MTA 70.70
  • 52 Week Low
  • SCPH $1.94
  • MTA $2.45
  • 52 Week High
  • SCPH $6.28
  • MTA $5.94
  • Technical
  • Relative Strength Index (RSI)
  • SCPH 63.97
  • MTA 62.68
  • Support Level
  • SCPH $4.33
  • MTA $5.45
  • Resistance Level
  • SCPH $5.62
  • MTA $5.94
  • Average True Range (ATR)
  • SCPH 0.04
  • MTA 0.30
  • MACD
  • SCPH -0.01
  • MTA -0.02
  • Stochastic Oscillator
  • SCPH 86.67
  • MTA 47.44

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.

About MTA Metalla Royalty & Streaming Ltd.

Metalla Royalty & Streaming Ltd is a precious metals royalty and streaming company, which engages in the acquisition and management of precious metal royalties, streams, and similar production-based interests. It's a pure-play gold and silver streaming and royalty company. It generates revenue from royalties, streams, and other interests.

Share on Social Networks: